Key Quantitative Figures
- Total Amount Raised: ₹39.78 crore (₹3978.15 lakh)
- Allotment Date: October 9, 2025
- Number of Warrants Allotted: 1,20,55,000 fully convertible warrants
- Issue Price: ₹33 per warrant
- Quarter Ended: March 31, 2026
Fund Utilization Breakdown (Cumulative as of March 31, 2026)
- Working Capital Requirements:
- Original Allocation: ₹41.69 crore (₹4168.80 lakh)
- Modified Allocation: ₹32.72 crore (₹3271.80 lakh)
- Actual Utilized: ₹10.86 crore (₹1085.56 lakh)
- Capital Expenditure:
- Original Allocation: ₹4.00 crore (₹400.00 lakh)
- Modified Allocation: ₹3.14 crore (₹313.93 lakh)
- Actual Utilized: ₹3.14 crore (₹313.93 lakh)
- General Corporate Purpose:
- Original Allocation: ₹4.65 crore (₹465.00 lakh)
- Modified Allocation: ₹3.65 crore (₹364.95 lakh)
- Actual Utilized: ₹1.12 crore (₹112.08 lakh)
- Issue Related Expenses:
- Original Allocation: ₹0.35 crore (₹35.00 lakh)
- Modified Allocation: ₹0.27 crore (₹27.47 lakh)
- Actual Utilized: ₹0.27 crore (₹27.47 lakh)
Additional Notes
1. The company initially sought BSE approval for 1,53,60,000 warrants which would have raised ₹50.69 crore (₹5068.80 lakh). However, actual applications were received for only 1,20,55,000 warrants, reducing the total amount raised to ₹39.78 crore. The board proportionately reduced fund allocations without changing the objects, requiring no shareholder approval.
2. The company received 25% of the issue price (₹9,94,53,750) with applications. The remaining 75% is to be received within 18 months per SEBI ICDR Regulations.
3. During the quarter, the company received balance funds from two shareholders requesting conversion of 22,00,000 warrants into equity shares. The board allotted 22,00,000 equity shares on March 30, 2026, receiving ₹5.45 crore (₹544,50,000) from this conversion.